Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7291 to 7305 of 7707 results

  1. COVID-19 rapid guideline: critical care in adults (NG159)

    This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.

    COVID-19 rapid guideline
    Last updated
    12 February 2021

  2. COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community (NG163)

    This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.

    COVID-19 rapid guideline
    Last updated
    13 October 2020

  3. COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders (NG167)

    27 May 2022: This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. For people with COVID-19 see our guideline on managing COVID-19. 

    COVID-19 rapid guideline
    Last updated
    31 March 2021

  4. Infection control: prevention of healthcare-associated infection in primary and community care (CG2)

    This guidance has been updated and replaced by NICE guideline CG139.    

    Clinical guideline
    Published
    25 June 2003

  5. The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care (CG20)

    This guideline has been updated and replaced by NICE guideline CG137.

    Clinical guideline
    Published
    27 October 2004

  6. Falls: the assessment and prevention of falls in older people (CG21)

    This guideline has been updated and replaced by NICE guideline CG161.

    Clinical guideline
    Published
    24 November 2004

  7. Anxiety: Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care (CG22)

    This guideline has been updated and replaced by NICE guideline CG113.

    Clinical guideline
    Published
    6 December 2004

  8. Depression: management of depression in primary and secondary care (CG23)

    This guidance has been updated and replaced by NICE guideline CG90.

    Clinical guideline
    Published
    6 December 2004

  9. Lung cancer: diagnosis and treatment (CG24)

    This guideline has been updated and replaced by NICE guideline CG121.

    Clinical guideline
    Published
    23 February 2005

  10. Violence: short-term management for over 16s in psychiatic and emergency departments (CG25)

    This guideline has been updated and replaced by NICE guideline NG10.

    Clinical guideline
    Published
    23 February 2005

  11. Post-traumatic stress disorder: management (CG26)

    This guidance has been updated and replaced by NICE guideline NG116.

    Clinical guideline
    Published
    23 March 2005

  12. Degarelix before or with radiotherapy for treating high-risk localised and locally advanced hormone-dependent prostate cancer [ID6419]

    In development [GID-TA11443] Expected publication date: TBC

    Technology appraisal guidance
    In development

  13. Empagliflozin for preventing cardiovascular events after acute myocardial infarction [ID6240]

    In development [GID-TA11265] Expected publication date: TBC

    Technology appraisal guidance
    In development

  14. Repotrectinib for treating ROS1-positive advanced non-small-cell lung cancer [ID6277]

    In development [GID-TA11302] Expected publication date: TBC

    Technology appraisal guidance
    In development

  15. Tafamidis for treating transthyretin amyloidosis with cardiomyopathy (TA696)

    This guidance has been updated and replaced by NICE technology appraisal guidance 984.

    Technology appraisal guidance
    Published
    12 May 2021